Long-term monitoring reveals enzyme activity as a predictive measure for abdominal pain in acute intermittent porphyria.
The relationship between the onset of abdominal pain attack and the urinary levels of δ-aminolevulinic acid, porphobilinogen, uroporphyrin, and the activity of erythrocyte porphobilinogen deaminase was studied on a monthly basis over a four-year period in a 29-year-old male patient with acute intermittent porphyria. A close relationship is seen between the onset of pain episodes and sharp decreases of porphobilinogen deaminase activity. The activity normalizes as the patient improves, suggesting that this enzyme is a more sensitive monitor for acute intermittent porphyria attacks than the urinary parameters currently used for its diagnosis. Our results suggest that month-by-month testing of porphobilinogen deaminase activity in acute intermittent porphyria patients is a good practice to predict episodes of acute abdominal pain before its onset, also allowing estimation of possible promoting factors and in establishing optimal specific therapies.
No takes yet. Share an insight, caveat, or question.
Tanaka et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: